(Q42972295)

English

A randomized, double-blind, multicenter, parallel-group, placebo-controlled, dose-optimization study of the methylphenidate transdermal system for the treatment of ADHD in adolescents

scientific article published on July 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

12 November 2017

A randomized, double-blind, multicenter, parallel-group, placebo-controlled, dose-optimization study of the methylphenidate transdermal system for the treatment of ADHD in adolescents (English)

1 reference

Europe PubMed Central

12 November 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Robert L Findling

1

object named as

Robert L Findling

1 reference

Europe PubMed Central

12 November 2017

author name string

John Turnbow

2

1 reference

Europe PubMed Central

12 November 2017

John Burnside

3

1 reference

Europe PubMed Central

12 November 2017

Raun Melmed

4

1 reference

Europe PubMed Central

12 November 2017

Rich Civil

5

1 reference

Europe PubMed Central

12 November 2017

Yunfeng Li

6

1 reference

Europe PubMed Central

12 November 2017

publication date

1 July 2010

1 reference

Europe PubMed Central

12 November 2017

C N S Spectrums

1 reference

Europe PubMed Central

12 November 2017

15

1 reference

Europe PubMed Central

12 November 2017

7

1 reference

Europe PubMed Central

12 November 2017

419-430

1 reference

Europe PubMed Central

12 November 2017

Functional magnetic resonance imaging of methylphenidate and placebo in attention-deficit/hyperactivity disorder during the multi-source interference task

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900000353

7 January 2021

based on heuristic

inferred from DOI database lookup

Multisite controlled study of OROS methylphenidate in the treatment of adolescents with attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900000353

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized, double-blind, placebo-controlled, laboratory classroom assessment of methylphenidate transdermal system in children with ADHD.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900000353

7 January 2021

based on heuristic

inferred from DOI database lookup

Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900000353

7 January 2021

based on heuristic

inferred from DOI database lookup

Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900000353

7 January 2021

based on heuristic

inferred from DOI database lookup

Indication and use of drug products used to treat attention-deficit/hyperactivity disorder: a cross-sectional study with inference on the likelihood of treatment in adulthood

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900000353

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of methylphenidate on the catecholaminergic system in attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900000353

7 January 2021

based on heuristic

inferred from DOI database lookup

Attention deficit/hyperactivity disorder across the lifespan

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900000353

7 January 2021

based on heuristic

inferred from DOI database lookup

The Texas Children's Medication Algorithm Project: revision of the algorithm for pharmacotherapy of attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900000353

7 January 2021

based on heuristic

inferred from DOI database lookup

Trends in medication treatment for ADHD.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900000353

7 January 2021

based on heuristic

inferred from DOI database lookup

Attention deficit/hyperactivity disorder and methylphenidate. A review of height/weight, cardiovascular, and somatic complaint side effects

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900000353

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of long-term atomoxetine treatment for young children with attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900000353

7 January 2021

based on heuristic

inferred from DOI database lookup

Practice Parameter for the Assessment and Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900000353

7 January 2021

based on heuristic

inferred from DOI database lookup

International consensus statement on attention-deficit/hyperactivity disorder (ADHD) and disruptive behaviour disorders (DBDs): clinical implications and treatment practice suggestions

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900000353

7 January 2021

based on heuristic

inferred from DOI database lookup

Global consensus on ADHD/HKD.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900000353

7 January 2021

based on heuristic

inferred from DOI database lookup

ADHD treatment with once-daily OROS methylphenidate: interim 12-month results from a long-term open-label study

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900000353

7 January 2021

based on heuristic

inferred from DOI database lookup

Methylphenidate and its Isomers

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900000353

7 January 2021

based on heuristic

inferred from DOI database lookup

Varying the wear time of the methylphenidate transdermal system in children with attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900000353

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900000353

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical practice guideline: treatment of the school-aged child with attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900000353

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term tolerability and effectiveness of once-daily mixed amphetamine salts (Adderall XR) in children with ADHD.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900000353

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1017/S1092852900000353

0 references

1 reference

Europe PubMed Central

12 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42972295&oldid=2129632882"